Modalert 200mg promotes wakefulness in patients with sleeping disorders
Modalert 200 mg is a sleep medication that helps promote wakefulness in sleepy patients. The drug works by altering natural chemicals in the brain that control response to concoctions.
It is commonly used to treat daytime sleepiness related to a sleeping disorder.
It is important to note, however, that the drug does not cure a sleeping disorder and should not be used to hold someone asleep.
This study found that Modalert 200mg promotes sleepfulness in patients with sleep disorders and improves the CGI-C score in patients with OSA.
Patients with OSA are characterized by excessive sleepiness and episodes of impaired breathing during sleep. They may also experience frequent morning headaches and dry mouth upon awakening.
Patients with OSA can also have polysomnography, which measures the number of apneas and the likelihood that they fall asleep during daily activities.
It promotes wakefulness
Modafinil (Modalert) is a CNS medication that promotes wakefulness in people who experience extreme sleepiness during the daytime. It works by affecting the brain areas that regulate attention and wakefulness.
The medication may be taken daily, or in some cases, just before bedtime. It is not recommended for healthy people.
The primary outcome in this trial was an improvement in the ESS, a questionnaire that asks patients to rate their likelihood of falling asleep during various situations.
The questionnaire is scored from one to 24. It was found that patients who took Modalert had improved ESS scores.
Modafinil significantly improved objectively determined sleepiness and lowered sleepiness on the ESS, as well as improved the overall clinical condition associated with extreme sleepiness.
In addition, it reduced patient-reported sleepiness, improved general productivity, and improved health-related quality of life. Moreover, modafinil was well tolerated in long-term studies.
The study also showed a significant improvement in wakefulness scores compared to baseline. Moreover, the two-daily regimens improved MWT sleep latency.
Split-dose regimens were found to be more effective than once-daily administration of modafinil. Moreover, both regimens were well tolerated.
